Faecal calprotectin as surrogate marker of transmural healing assessed using MRI in patients with Crohn's disease - Vigipallia

0 avis

Faecal calprotectin as surrogate marker of transmural healing assessed using MRI in patients with Crohn's disease

Archive ouverte

Allimant, C. | Messadeg, L. | Quinard, R. Minet | Goutte, Marion | Bouvier, D. | Goutorbe, F. | Pereira, B. | Bommelaer, G. | Hordonneau, C. | Buisson, A.

Edité par CCSD ; Oxford University Press -

International audience

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Definition of therapeutic response criteria using MRI in Crohn's disease patients treated with anti-TNF therapy: a multicenter prospective study (the IRMA study)

Archive ouverte | Buisson, A. | CCSD

International audience

MRI remission after therapeutic intervention is associated with more time spent in clinical corticosteroids-free remission and decreased risk of surgery in Crohn's disease

Archive ouverte | Buisson, A. | CCSD

International audience

The variation of faecal calprotectin after 3 months of anti-TNF therapy is a predictor of sustained clinical remission in patients with Crohn's disease

Archive ouverte | Sollelis, E. | CCSD

International audience

Chargement des enrichissements...